NCT05342532View on ClinicalTrials.gov

High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population

PHASE4CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

June 12, 2019

Primary Completion Date

January 1, 2022

Study Completion Date

January 1, 2022

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Amoxicillin

1 g

DRUG

Omeprazole

40 mg. Patients were asked to take omeprazole one hour prior to food intake, while antibiotics were taken after meals.

DRUG

Clarithromycin

500 mg twice daily

Trial Locations (1)

10003

Mount Sinai Union Square Division of Digestive Diseases, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT05342532 - High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population | Biotech Hunter | Biotech Hunter